XML 43 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1

Restructuring Activities (Tables)

9 Months Ended

Sep. 30, 2017

Restructuring and Related Activities [Abstract]

Restructuring and Related Costs [Table Text Block]

The following table is a summary of the severance and other restructuring costs, which included employee-related costs, facility rent and exit costs, relocation, recruiting, travel and other, for the three months and nine months ended September 30, 2017 and 2016:

	Three Months Ended September 30,								Nine Months Ended September 30,
	2017				2016				2017				2016
Severance:
Cost of sales	$	52			$	159			$	731			$	3,501
Selling, general, and administrative expenses	920				43				2,767				2,382
Total severance costs	$	972			$	202			$	3,498			$	5,883
Other restructuring:
Cost of sales	$	278			$	—			$	4,072			$	—
Selling, general, and administrative expenses	1,499				103				4,847				420
Total other restructuring costs	$	1,777			$	103			$	8,919			$	420
Total restructuring costs	$	2,749			$	305			$	12,417			$	6,303

Schedule of Restructuring Accrual by Type of Cost [Table Text Block]

The following tables summarize the Company’s restructuring activities for the three and nine months ended September 30, 2017 and 2016:

	Three Months Ended September 30, 2017
	Energy & Chemicals				Distribution & Storage				BioMedical				Corporate				Total
Balance as of June 30, 2017	$	—			$	1,865			$	847			$	1,493			$	4,205
Restructuring costs	162				648				516				1,423				2,749
Cash payments	(157		)		(1,381		)		(803		)		(1,480		)		(3,821		)
Acquired restructuring reserve	194				—				—				—				194
Balance as of September 30, 2017	$	199			$	1,132			$	560			$	1,436			$	3,327

	Three Months Ended September 30, 2016
	Energy & Chemicals				Distribution & Storage				BioMedical				Corporate				Total
Balance as of June 30, 2016	$	544			$	4,796			$	368			$	276			$	5,984
Restructuring costs	159				118				—				28				305
Cash payments	(267		)		(1,160		)		(168		)		(219		)		(1,814		)
Balance as of September 30, 2016	$	436			$	3,754			$	200			$	85			$	4,475

	Nine Months Ended September 30, 2017
	Energy & Chemicals				Distribution & Storage				BioMedical				Corporate				Total
Balance as of December 31, 2016	$	127			$	2,864			$	1,308			$	3,025			$	7,324
Restructuring costs	2,245				1,085				4,527				4,560				12,417
Cash payments	(2,367		)		(2,817		)		(5,275		)		(6,149		)		(16,608		)
Acquired restructuring reserve	194				—				—				—				194
Balance as of September 30, 2017	$	199			$	1,132			$	560			$	1,436			$	3,327

	Nine Months Ended September 30, 2016
	Energy & Chemicals				Distribution & Storage				BioMedical				Corporate				Total
Balance as of December 31, 2015	$	1,106			$	3,446			$	430			$	850			$	5,832
Restructuring costs	821				3,929				521				1,032				6,303
Cash payments	(1,491		)		(3,621		)		(751		)		(1,797		)		(7,660		)
Balance as of September 30, 2016	$	436			$	3,754			$	200			$	85			$	4,475

X

- References

No definition available.

+ Details

Name:	us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB TOPIC 5.P.4)
-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

Reference 3: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 5.P.3)
-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140864-122747

+ Details

Name:	us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost. This element may also include a description of any reversal and other adjustment made during the period to the amount of an accrued liability for restructuring activities. This element may be used to encapsulate the roll forward presentations of an entity's restructuring reserve by type of cost and in total, and explanation of changes that occurred in the period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 420
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 5.P.4(b)(2))
-URI http://asc.fasb.org/extlink&oid=27011515&loc=d3e140904-122747

+ Details

Name:	us-gaap_ScheduleOfRestructuringReserveByTypeOfCostTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration